查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018567

3D列印手術模型市場：按技術、材料、模型類型、應用和最終用戶分類－2026-2032年全球市場預測

3D Printed Surgical Models Market by Technology, Material, Model Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，3D 列印手術模型市場價值將達到 8.5989 億美元，到 2026 年將成長至 9.7127 億美元，到 2032 年將達到 21.305 億美元，複合年成長率為 13.83%。

主要市場統計數據
基準年 2025 859,890,000 美元
預計年份：2026年 9.7127億美元
預測年份 2032 21.305億美元
複合年成長率 (%) 13.83%

簡要概述技術成熟度和臨床重點如何融合，使 3D 列印手術模型成為現代外科實踐中的基本要素。

3D列印技術已迅速從實驗室驗證階段發展成為外科手術規劃、教學以及為患者創建個人化解決方案的關鍵要素。隨著臨床團隊致力於改善手術效果，醫療設備設計師不斷突破個人化的界限，3D列印的解剖模型能夠實現更精確的術前模擬和更有效率的跨學科協作。列印技術、材料科學和影像整合領域的同步進步正在提升手術模型的精確度、可重複性和臨床有效性，從而重塑醫療團隊為複雜介入手術所做的準備。

技術、臨床和供應鏈進步的融合正在加速 3D 列印手術模型的採用，並重塑經營模式。

3D列印手術模式領域正經歷一場變革，其驅動力來自技術創新、臨床需求以及策略性供應鏈決策。在技​​術層面，從高解析度立體光刻技術和材料噴塗到穩健的粉末床熔融和黏著劑噴塗成型等多種列印工藝，使得模型能夠精確地再現軟組織對比度、硬骨解剖結構以及複雜結構。同時，聚合物、金屬和陶瓷領域的創新滿足了多模態模擬的需求，拓展了3D列印模型的應用範圍，使其涵蓋教育、術前規劃和手術演練等領域。

對美國關稅政策的變化如何影響 3D 列印外科模型生態系統中的供應鏈決策、籌資策略和本地化進行基於證據的檢驗。

近期推出的關稅政策和貿易措施進一步加劇了3D列印手術模型設備、耗材和原料相關人員的複雜性。進口醫療設備、高價值金屬和特殊聚合物原料的關稅推高了採購成本，並改變了外包和本地生產的經濟效益。因此，醫療服務提供者和服務機構正在重新審視籌資策略和總成本結構，以維持臨床能力和預算的可預測性。

這種多軸分割觀點闡明了技術方法、材料選擇、模型類型、臨床應用和最終用戶需求如何相互作用，從而決定外科模型的採用路徑。

要理解這一領域，必須關注多個細分維度，這些維度定義了技術選擇、材料選擇、模型類型、臨床應用和最終用戶需求。基於技術，市場參與企業會評估各種列印方法，例如黏著劑噴塗、熔融沈積成型 (FDM)、材料噴射、粉末層熔融和立體光刻技術。每種方法在解析度、速度和材料相容性方面各有優劣，從而決定是否適用於特定的手術場景。基於材料，相關人員會考慮陶瓷、金屬和聚合物等選項。在此，機械性質、可滅菌性和影像可重複性等因素會影響訓練模型和植入原型模型的選擇標準。基於模型類型，產品分為通用模型和患者特異性模型。通用模型針對教育、手術演示和培訓等應用場景進行了進一步最佳化，而患者特異性模型則支援客製化植入設計、術前模擬和手術規劃等需要影像整合和臨床檢驗的工作流程。根據應用領域，循環系統、牙科、神經病學、整形外科和泌尿系統等臨床專科各自具有獨特的解剖學和功能性需求，這些需求指導著材料和技術的選擇，並影響它們的臨床應用。根據最終用戶的不同，診斷中心、醫院和研究機構的需求也各不相同，每個機構優先考慮的性能指標也不同，例如處理時間、可重複性、法規支援和成本效益。

美洲、歐洲、中東和非洲以及亞太地區的區域醫療保健重點、法規環境和製造業投資如何影響外科手術模式的採用和創新？

區域趨勢對整個醫療保健系統中3D列印手術模型的開發、監管和應用起著至關重要的作用。美洲市場通常需求強勁，這得益於先進的臨床研究計畫、醫院的廣泛應用以及緊密的專業服務供應商生態系統。在此背景下，重點在於將高度精確的、患者特異性的模型整合到術前規劃流程中，並將技術優勢轉化為可驗證的臨床結果。在該地區的部分地區，明確的法規和完善的報銷流程進一步促進了臨床初步試驗和醫院層面的應用。

深入了解技術供應商、材料專家和服務供應商如何透過臨床夥伴關係、垂直整合和檢驗能力來推動 3D 列印手術模型的普及應用。

3D列印手術模型生態系統中各公司的策略體現了技術領先、材料專長和服務差異化之間的平衡。儀器和平台供應商優先考慮解析度、速度和流程檢驗，以滿足臨床需求，並投資於工作流程整合，將成像系統與可列印工具和軟體連接起來。材料供應商強調醫用級配方、無菌性和認證支持，以減少臨床應用的障礙。同時，服務供應商和臨床創新者則專注於檢驗且可重複的流程，以展現可重複的解剖學精度和功能效用。

為高階主管提供切實可行的策略舉措，以加速外科模型解決方案的臨床部署，增強供應鏈韌性，並建立可擴展的商業性路徑。

致力於加速技術應用並創造臨床價值的產業領導者應制定一系列切實可行的優先事項，將技術、臨床協作和營運韌性結合在一起。首先，投資成熟的影像到列印工作流程，以減少分割誤差，並促進臨床醫生和生產團隊之間的快速迭代。這可以最大限度地縮短週期時間，提高臨床可靠性。其次，在產品開發早期階段就應優先考慮材料合格和滅菌流程，以縮短設施檢驗週期，並在必要時確保術中安全使用。

採用透明、嚴謹的研究途徑，結合與臨床相關人員的訪談、技術檢驗和監管路徑分析，以確保調查結果的可重複性。

本分析所依據的研究結合了對臨床相關人員的定性訪談、對列印流程的技術檢驗，以及對影響技術推廣應用的監管和政策趨勢的系統性回顧。初步訪談對象包括外科醫生、醫院採購經理、生物醫學工程師和材料科學家，旨在了解實際工作流程和推廣應用障礙。這些訪談有助於評估跨學科技術適用性、材料性能要求和操作限制。

一項權威的綜合分析，重點關注臨床、運營和協作要求，以確定哪些醫療機構可以從 3D 列印手術模型中獲得最大價值。

總之，3D列印手術模型有望透過改善術前規劃、加強手術培訓以及支持患者個人化醫療設備的創新，帶來持久的臨床價值。成熟的列印技術、檢驗的材料以及整合的成像工作流程相結合，使其能夠在多個專科領域得到應用；然而，收費系統和供應鏈韌性等營運現實正在重塑戰略採購和生產基地的選址。將臨床初步試驗與嚴格檢驗相結合，並投資於標準化合格材料和工作流程的醫療機構將從中獲益最多。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：3D列印手術模型市場：依技術分類

  • 黏著劑噴塗成型
  • 積層製造
  • 材料噴塗
  • 粉末床沉積
  • 立體光刻技術

第9章：3D列印手術模型市場：依材料分類

  • 陶瓷製品
  • 金屬
  • 聚合物

第10章：按模型類型分類的3D列印手術模型市場

  • 一般
    • 為了教育
    • 技術演示
    • 訓練
  • 患者特定
    • 客製化植入設計
    • 術前模擬
    • 手術計劃

第11章：3D列印手術模型市場：按應用領域分類

  • 循環系統
  • 牙科
  • 神經病學
  • 整形外科
  • 泌尿系統

第12章：3D列印手術模型市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 研究機構

第13章：3D列印手術模型市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：3D列印手術模型市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 3D列印手術模型市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國3D列印手術模型市場

第17章：中國3D列印手術模型市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3D Systems Corporation
  • Anatomiz3D Medtech Private Limited
  • Aspect Biosystems Ltd
  • Axial3D
  • Carbon Inc
  • Cellink
  • Cyfuse Biomedical KK
  • Desktop Metal Inc
  • EnvisionTEC GmbH
  • EOS GmbH
  • Formlabs Inc
  • General Electric Company
  • HP Inc
  • Materialise NV
  • Medacta International SA
  • Medtronic plc
  • Nikon SLM Solutions AG
  • Organovo Holdings Inc
  • Prodways Group
  • Protolabs Inc
  • Renishaw plc
  • Stratasys Ltd
  • Stryker Corporation
  • Voxeljet AG
  • Zimmer Biomet Holdings Inc
Product Code: MRR-B9334AD6BE9C

The 3D Printed Surgical Models Market was valued at USD 859.89 million in 2025 and is projected to grow to USD 971.27 million in 2026, with a CAGR of 13.83%, reaching USD 2,130.50 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 859.89 million
Estimated Year [2026] USD 971.27 million
Forecast Year [2032] USD 2,130.50 million
CAGR (%) 13.83%

A concise overview of how technological maturation and clinical priorities are converging to make 3D printed surgical models a foundational component of modern surgical practice

Three-dimensional printing has rapidly matured from experimental laboratory demonstrations to an integral part of surgical planning, education, and the fabrication of patient-specific solutions. As clinical teams pursue improved procedural outcomes and medical device designers push the boundaries of personalization, printed anatomical models are enabling higher-fidelity preoperative simulations and more efficient interdisciplinary collaboration. Concurrent advances in printing technologies, materials science, and imaging integration have elevated the precision, reproducibility, and clinical relevance of surgical models, reshaping how care teams prepare for complex interventions.

Moreover, the clinical value proposition is becoming clearer: tactile, anatomically accurate models support risk reduction during high-complexity procedures by enabling rehearsal, implant fitting, and multidisciplinary planning sessions. These practical benefits are driving cross-functional adoption across specialties such as cardiovascular, orthopedics, neurology, dentistry, and urology. Complementing clinical uptake, academic and training institutions rely on printed models to enhance competency-based education and simulation curricula, bridging the gap between theoretical knowledge and hands-on procedural skills.

Transitioning from prototype to routine use requires alignment among clinicians, supply chain stakeholders, and regulatory bodies. Accordingly, this report frames the evolving ecosystem that supports clinical adoption, identifies the technological and material vectors that underpin product performance, and highlights the organizational capabilities necessary to implement reproducible, clinically validated workflows for both patient-specific and generic models.

How converging technological, clinical, and supply chain evolutions are accelerating adoption and reshaping commercial models for 3D printed surgical models

The landscape for 3D printed surgical models is undergoing transformative shifts driven by technological innovation, clinical demand, and strategic supply chain decisions. On the technological front, diversified printing processes-from high-resolution stereolithography and material jetting to robust powder bed fusion and binder jetting-are enabling models that accurately represent soft-tissue contrast, rigid bony anatomy, and composite structures. Simultaneously, materials innovation in polymers, metals, and ceramics supports multi-modal simulation needs, extending the applicability of printed models across education, preoperative planning, and procedural rehearsal.

Clinically, a shift toward personalization is reshaping stakeholder expectations. Patient-specific models are increasingly used for custom implant design, preoperative simulation, and surgical planning, which demands tighter integration of imaging modalities, segmentation workflows, and validation protocols. In parallel, generic models retain a critical role in educational settings and procedural demonstrations, supporting scalable training and competency assessments. These concurrent trends underscore a bifurcated adoption pathway where tailored clinical solutions coexist with standardized educational tools.

From an operational perspective, the value chain is consolidating around vertically integrated offerings that combine imaging-to-print software, validated materials, and clinical services. This integration reduces time-to-use and mitigates risk, while also encouraging new commercial collaborations between printing specialists, clinical teams, and materials suppliers. In short, the sector is moving from isolated proof-of-concept projects to repeatable, institutionally adopted workflows that prioritize clinical relevance, reproducibility, and regulatory alignment.

An evidence-based examination of how evolving United States tariff measures are reshaping supply chain decisions, procurement strategies, and localization in the 3D printed surgical models ecosystem

Recent tariff policies and trade actions have introduced a layer of complexity for stakeholders procuring equipment, consumables, and raw materials for 3D printed surgical models. Tariffs on imported devices, high-value metals, and specialized polymer feedstocks can increase procurement costs and change the economics of outsourcing versus local production. As a result, healthcare providers and service bureaus are re-evaluating sourcing strategies and total cost structures to maintain clinical throughput and budgetary predictability.

In response, several strategic adjustments have emerged across the value chain. Procurement teams are negotiating longer-term supply agreements to stabilize pricing and lead times, while manufacturers are diversifying supplier portfolios to mitigate exposure to single-country risks. Additionally, the tariffs environment has encouraged investment in domestic production capabilities and validated in-country supply chains for critical materials such as medical-grade polymers and metal powders. This localization reduces tariff vulnerability but requires capital expenditure and regulatory oversight to ensure consistent quality and biocompatibility.

Moreover, tariffs influence the competitive dynamics of service provision. Organizations that can internalize printing capabilities or vertically integrate materials procurement gain greater resilience against import-related cost volatility. Conversely, smaller providers and research institutes that rely on imported equipment may face higher entry barriers, prompting collaboration, consortia purchasing, or cloud-based access models to preserve access to advanced printing platforms. Ultimately, policy-driven cost pressures are accelerating strategic shifts toward supply chain redundancy, regional manufacturing footprints, and closer alignment between clinical demand and production capacity.

A multi-axis segmentation perspective revealing how technology modalities, material choices, model typologies, clinical applications, and end-user needs collectively determine adoption pathways for surgical models

Understanding the sector requires attention to multiple segmentation axes that define technology choice, material selection, model typology, clinical application, and end-user needs. Based on Technology, market participants evaluate printing modalities including binder jetting, fused deposition modeling, material jetting, powder bed fusion, and stereolithography, each offering distinct trade-offs in resolution, speed, and material compatibility that determine suitability for specific surgical scenarios. Based on Material, stakeholders consider ceramic, metal, and polymer options where factors such as mechanical properties, sterilizability, and imaging fidelity influence selection criteria for training models versus implant prototypes. Based on Model Type, offerings split between generic and patient specific categories; the Generic models are further tailored for educational, procedural demonstration, and training use cases, while the Patient Specific models support custom implant design, preoperative simulation, and surgical planning workflows that demand imaging integration and clinical validation. Based on Application, clinical specialties including cardiovascular, dentistry, neurology, orthopedics, and urology present unique anatomic and functional requirements that guide both material and technology choices and influence clinical uptake. Based on End User, demand profiles differ across diagnostic centers, hospitals, and research institutes with each segment valuing different performance metrics such as turnaround time, reproducibility, regulatory support, and cost-efficiency.

Taken together, these segmentation lenses reveal that adoption is not uniform: clinical application and end-user context often dictate which technologies and materials will achieve practical impact. For example, high-resolution stereolithography and material jetting frequently meet the fidelity needs for neurosurgical planning, whereas powder bed fusion and metal processing are central for implant prototyping in orthopedics. Similarly, polymer-based generic models retain broad utility in educational environments where cost-effectiveness and repeatability matter most. These dynamics highlight the importance of aligning technology and material strategies with explicit clinical objectives and institutional capabilities.

How regional healthcare priorities, regulatory environments, and manufacturing investments across the Americas, Europe Middle East & Africa, and Asia-Pacific are shaping adoption and innovation for surgical models

Regional dynamics play a pivotal role in shaping how 3D printed surgical models are developed, regulated, and adopted across healthcare systems. Americas markets typically exhibit strong demand driven by advanced clinical research programs, widespread hospital adoption, and a dense ecosystem of specialty service providers. In these contexts, emphasis lies on integrating high-fidelity patient-specific models into surgical planning pathways and translating technical advantages into demonstrable clinical outcomes. Regulatory clarity and established reimbursement pathways in parts of the region further support clinical pilots and hospital-level deployment.

In Europe, Middle East & Africa, the landscape demonstrates heterogeneity driven by varied regulatory frameworks, healthcare funding mechanisms, and differential access to capital. Several countries within this region emphasize collaborative research initiatives and cross-border partnerships to accelerate validation studies and enable shared access to printing infrastructure. Standards harmonization and regional regulatory convergence remain priorities to reduce friction for clinical use and facilitate broader adoption across public and private healthcare providers.

Asia-Pacific represents a rapidly evolving environment with significant investments in domestic manufacturing, materials innovation, and academic-clinical partnerships. Governments and private investors are prioritizing local capability development to support both export-oriented manufacturing and in-country clinical use. Across this region, rapid hospital expansion and a growing focus on surgical quality improvement create fertile ground for both generic training models and patient-specific solutions, while regional supply-chain initiatives aim to secure access to critical printing materials and equipment.

Insights into how technology vendors, materials specialists, and service providers are aligning clinical partnerships, vertical integration, and validation capabilities to drive adoption of printed surgical models

Company strategies in the 3D printed surgical model ecosystem reflect a balance between technological leadership, materials expertise, and service-level differentiation. Equipment and platform providers prioritize resolution, speed, and process validation to meet clinical requirements, investing in workflow integrations that link imaging systems with print-ready tooling and software. Materials suppliers emphasize medical-grade formulations, sterilizability, and certification support to reduce clinical adoption friction, while service bureaus and clinical innovators focus on validated, repeatable processes that demonstrate reproducible anatomical accuracy and functional utility.

Partnership models are increasingly prevalent: clinical centers collaborate with technology providers to co-develop application-specific model libraries, and materials manufacturers work closely with validation labs to accelerate material qualification. At the same time, some firms pursue vertical integration by combining imaging segmentation software, printing hardware, and post-processing services to offer end-to-end solutions that reduce institutional complexity. These integrated offerings often include training modules, quality management documentation, and regulatory support to aid hospital adoption.

Competitive differentiation also arises from domain expertise-companies that bring deep clinical insight into specialty workflows can tailor products to surgeon needs and demonstrate outcome-driven value. In parallel, firms that invest in scalable production capabilities and strong supply chain relationships mitigate tariff and sourcing risks, positioning themselves as reliable partners for large-scale hospital systems and research consortia.

A practical set of strategic moves for executives to accelerate clinical adoption, strengthen supply chain resilience, and create scalable commercial pathways for surgical model solutions

Industry leaders seeking to accelerate adoption and generate clinical value should pursue a set of actionable priorities that align technology, clinical engagement, and operational resilience. First, invest in proven imaging-to-print workflows that reduce variability in segmentation and enable faster iteration between clinicians and production teams; this minimizes cycle time and improves clinical confidence. Second, prioritize materials qualification and sterilization pathways early in product development to shorten institutional validation timelines and ensure safe intraoperative use when required.

Third, develop collaborative pilot programs with specialty surgical teams to collect objective performance metrics and publish real-world case studies that underscore clinical benefits. These partnerships should include training curricula and competency assessments to embed models into standard operating procedures. Fourth, diversify supply chains and explore regional manufacturing partnerships to reduce exposure to import tariffs and logistic disruptions; coupling local production capacity with centralized quality oversight can balance resilience and economies of scale.

Finally, adopt modular commercial approaches that accommodate both generic educational customers and institutions seeking patient-specific services. Offer flexible licensing, metered service models, or subscription-based access to libraries of validated model designs to lower entry barriers for smaller providers while preserving premium service tiers for complex, patient-specific use. Collectively, these actions create a pathway for sustainable clinical integration and commercial scalability.

A transparent and rigorous research approach combining clinical stakeholder interviews, technical validation exercises, and regulatory pathway analysis to ensure reproducible insights

The research underpinning this analysis combines qualitative engagement with clinical stakeholders, technical validation of printing processes, and a structured review of regulatory and policy trends that influence adoption. Primary interviews were conducted with surgeons, hospital procurement leaders, biomedical engineers, and materials scientists to capture real-world workflows and adoption barriers. These engagements informed assessments of technology suitability, material performance requirements, and operational constraints across specialty areas.

In addition, technical validation exercises evaluated the relative strengths of dominant printing technologies-such as stereolithography for high-resolution anatomical fidelity and powder bed fusion for structurally demanding prototypes-alongside material characterization for polymers, metals, and ceramics. Regulatory landscape analysis reviewed current pathways for device classification, sterilization guidance, and institutional credentialing processes that affect clinical deployment. Secondary research supplemented primary insights by examining recent clinical publications, standards updates, and procurement trends to ensure a comprehensive synthesis.

Where relevant, the methodology emphasizes reproducibility and transparency: criteria for technology selection, material acceptance, and clinical validation are described to enable stakeholders to replicate evaluation protocols. Limitations of the research are acknowledged, including rapidly changing policies and evolving material innovations that require ongoing monitoring and periodic reassessment.

A conclusive synthesis emphasizing the clinical, operational, and collaborative imperatives that will determine which institutions capture the most value from 3D printed surgical models

In conclusion, 3D printed surgical models are positioned to deliver sustained clinical value by improving preoperative planning, enhancing procedural training, and supporting patient-specific device innovation. The convergence of mature printing technologies, validated materials, and integrated imaging workflows is enabling adoption across multiple specialties, while operational realities such as tariffs and supply chain resilience are reshaping strategic sourcing and production footprints. Institutions that align clinical pilots with rigorous validation and that invest in qualified materials and workflow standardization will realize the greatest benefits.

Looking ahead, the most impactful innovations will come from collaborations that bridge clinical insight with manufacturing capabilities-embedding iterative feedback loops between surgeons, engineers, and materials scientists. Standardized validation metrics and shared clinical outcome studies will help translate technical advantages into demonstrable patient benefits. By prioritizing interoperability, quality management, and regional supply agreements, healthcare organizations and providers can mitigate policy-driven cost pressures while accelerating the clinical integration of both generic and patient-specific printed models.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. 3D Printed Surgical Models Market, by Technology

  • 8.1. Binder Jetting
  • 8.2. Fused Deposition Modeling
  • 8.3. Material Jetting
  • 8.4. Powder Bed Fusion
  • 8.5. Stereolithography

9. 3D Printed Surgical Models Market, by Material

  • 9.1. Ceramic
  • 9.2. Metal
  • 9.3. Polymer

10. 3D Printed Surgical Models Market, by Model Type

  • 10.1. Generic
    • 10.1.1. Educational
    • 10.1.2. Procedural Demonstration
    • 10.1.3. Training
  • 10.2. Patient Specific
    • 10.2.1. Custom Implant Design
    • 10.2.2. Preoperative Simulation
    • 10.2.3. Surgical Planning

11. 3D Printed Surgical Models Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Dentistry
  • 11.3. Neurology
  • 11.4. Orthopedics
  • 11.5. Urology

12. 3D Printed Surgical Models Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Hospitals
  • 12.3. Research Institutes

13. 3D Printed Surgical Models Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. 3D Printed Surgical Models Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. 3D Printed Surgical Models Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States 3D Printed Surgical Models Market

17. China 3D Printed Surgical Models Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3D Systems Corporation
  • 18.6. Anatomiz3D Medtech Private Limited
  • 18.7. Aspect Biosystems Ltd
  • 18.8. Axial3D
  • 18.9. Carbon Inc
  • 18.10. Cellink
  • 18.11. Cyfuse Biomedical K.K.
  • 18.12. Desktop Metal Inc
  • 18.13. EnvisionTEC GmbH
  • 18.14. EOS GmbH
  • 18.15. Formlabs Inc
  • 18.16. General Electric Company
  • 18.17. HP Inc
  • 18.18. Materialise NV
  • 18.19. Medacta International SA
  • 18.20. Medtronic plc
  • 18.21. Nikon SLM Solutions AG
  • 18.22. Organovo Holdings Inc
  • 18.23. Prodways Group
  • 18.24. Protolabs Inc
  • 18.25. Renishaw plc
  • 18.26. Stratasys Ltd
  • 18.27. Stryker Corporation
  • 18.28. Voxeljet AG
  • 18.29. Zimmer Biomet Holdings Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL 3D PRINTED SURGICAL MODELS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY BINDER JETTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY BINDER JETTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY BINDER JETTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY FUSED DEPOSITION MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY FUSED DEPOSITION MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL JETTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL JETTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL JETTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY POWDER BED FUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY POWDER BED FUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY POWDER BED FUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY STEREOLITHOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY EDUCATIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY EDUCATIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY EDUCATIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PROCEDURAL DEMONSTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PROCEDURAL DEMONSTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PROCEDURAL DEMONSTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CUSTOM IMPLANT DESIGN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CUSTOM IMPLANT DESIGN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CUSTOM IMPLANT DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PREOPERATIVE SIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PREOPERATIVE SIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PREOPERATIVE SIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY SURGICAL PLANNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY SURGICAL PLANNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY SURGICAL PLANNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY DENTISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 160. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 161. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 184. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 185. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 192. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 193. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. NATO 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL 3D PRINTED SURGICAL MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY PATIENT SPECIFIC, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA 3D PRINTED SURGICAL MODELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)